The Non-Malignant Channel is supported with funding from Agios (Gold).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASH 2018 | Opioid use in sickle cell is not associated with in-hospital mortality in the US

Name: Opioid use in sickle cell is not associated with in-hospital mortality in the US
Uploaded: 2018-12-02T00:00:00.000Z
Duration: 7 min 37 s
Description: Oladimeji Akinola Akinboro, MBBS, of Boston University School of Medicine and Boston Medical Center, Boston, MA, presents the finding from a national inpatient sample of sickle cell disease (SCD) in the US, which revealed that opioid use in SCD patients is not associated with in-hospital mortality. This indicates that use for pain management appears safe and should not be witheld when indicated.

Oladimeji Akinola Akinboro • 2 Dec 2018

ASH 2018

Non-Malignant Sickle Cell Disease

Oladimeji Akinola Akinboro, MBBS, of Boston University School of Medicine and Boston Medical Center, Boston, MA, presents the finding from a national inpatient sample of sickle cell disease (SCD) in the US, which revealed that opioid use in SCD patients is not associated with in-hospital mortality. This indicates that use for pain management appears safe and should not be witheld when indicated.

ASH 2018 | Opioid use in sickle cell is not associated with in-hospital mortality in the US

Related Videos